Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 700, pseudogene (RN7SL700P)

Target
RN7SL700P
Molecular classification
Pseudogene, Non-coding RNA fragment, processed pseudogene
01

Overview

RNA, 7SL, cytoplasmic 700, pseudogene (RN7SL700P) is classified as a processed pseudogene, representing a non-functional, partial, or truncated copy of the functional 7SL RNA gene sequence[4][7]. While the canonical 7SL RNA plays a key role as a structural RNA in the signal recognition particle (SRP) ribonucleoprotein complex involved in co-translational protein targeting to the endoplasmic reticulum[1][3], the 7SL pseudogenes—including RN7SL700P—do not produce functional RNA products and lack biological roles in active cellular processes. Instead, these pseudogenes are considered remnants of ancient retrotransposition events in the human genome, often lacking regulatory regions or critical gene segments necessary for transcription and function[7]. Additional explanation and context: - Most 7SL "pseudogenes" are genomic relics derived from the retrotransposition of 7SL RNA sequences and do not produce functional RNAs[7]. Only a small number of true, transcriptionally active 7SL RNA genes exist in the human genome; the rest, like RN7SL700P, are considered inactive byproducts. - “RNA, 7SL, cytoplasmic” refers to a family of RNAs associated with the signal recognition particle (SRP), crucial for directing newly synthesized proteins to the endoplasmic reticulum. The pseudogene form RN7SL700P is not expressed or functional in this pathway[7]. - There are no known drugs, biomarkers, disease associations, or safety concerns related to this specific pseudogene since it does not encode a functional product. - The target entry is considered “incorrect” in a pharmacological or therapeutic context as it is neither a receptor, enzyme, nor any actionable therapeutic biomolecule. Summary of main issues: - RN7SL700P is a pseudogene and not a druggable target, nor involved in any confirmed biological or disease process. - Its record may be included in databases for genome annotation and evolutionary studies, but it is irrelevant as a therapeutic target[4][7].

Other names
RN7SL700PRNA, 7SL, cytoplasmic 700, pseudogene

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 700, pseudogene (RN7SL700P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 700, pseudogene (RN7SL700P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call